KDR and pancreatic neuroendocrine tumor: Similarly, in another Rip1Tag2 model of pancreatic neuroendocrine tumors, VEGFR2 blockade by anti-VEGFR2 monoclonal antibody DC101 upregulated both ANG2 and TIE2 expression and enhanced the infiltration of TIE2-expressing macrophages [44].